National Institute On Drug Abuse; Notice of Closed Meeting, 56780 [07-4931]
Download as PDF
<![CDATA[
56780
Federal Register / Vol. 72, No. 192 / Thursday, October 4, 2007 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.242, Mental Health Research
Grants, 93.281, Scientist Development
Award, Scientist Development Award for
Clinicians, and Research Scientist Award;
93.282, Mental Health National Research
Service Awards for Research Training,
National Institutes of Health, HHS)
Dated: September 27, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–4929 Filed 10–3–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute On Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
pwalker on PROD1PC71 with NOTICES
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel,
MIDARP Review.
Date: November 14, 2007.
Time: 12 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Mark Swieter, PhD, Chief,
Training and Special Projects Review Branch,
Office of Extramural Affairs, National
Institute on Drug Abuse, NIH, DHHS, 6101
Executive Boulevard, Suite 220, Bethesda,
MD 20892–8401, (301) 435–1389,
ms80x@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: September 27, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–4931 Filed 10–03–07; 8:45 am]
BILLING CODE 4140–01–M
VerDate Aug<31>2005
16:20 Oct 03, 2007
Jkt 214001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Cellular and
Molecular Immunology—B Study
Section, October 11, 2007, 8:30 a.m. to
October 12, 2007, 5 p.m., Residence Inn
Bethesda, 7335 Wisconsin Avenue,
Bethesda, MD 20814 which was
published in the Federal Register on
September 21, 2007, 72 FR 54051–
54054.
The meeting will be held at the Hilton
Hotel/Silver Spring, 8727 Colesville
Road, Silver Spring, MD 20910. The
meeting dates and times remain the
same. The meeting is closed to the
public.
Dated: September 27, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–4919 Filed 10–3–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Musculoskeletal, Oral
and Skin Sciences Integrated Review Group,
Skeletal Biology Structure and Regeneration
Study Section.
Date: October 15–16, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The William F. Bolger Center, The
Main Building, 9600 Newbridge Drive,
Potomac, MD 20854.
Contact Person: Mehrdad M. Tondravi,
PhD, Scientific Review Administrator, Center
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4108,
MSC 7814, Bethesda, MD 20892, 301–435–
1173, tondravm@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflicts: Community-Level Health
Influences and Interventions.
Date: October 23, 2007.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Valerie Durrant, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3148,
MSC 7770, Bethesda, MD 20892, (301) 435–
3554, durrantv@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflicts: Chemosensory.
Date: October 24, 2007.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Joseph G. Rudolph, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5186,
MSC 7844, Bethesda, MD 20892, 301–435–
2212, josephru@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Neurodevelopment, Synaptic Plasticity and
Neurodegeneration.
Date: October 25–26, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Jurys Washington Hotel, 1500 New
Hampshire Avenue, Washington, DC 20036.
Contact Person: Vilen A. Movsesyan, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040M,
MSC 7806, Bethesda, MD 20892, 301–402–
7278, movsesyanv@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, ZRG1 DIG
F(02) M Special Emphasis Panel Members.
Date: October 25, 2007.
Time: 10:30 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Rass M. Shayiq, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2182,
MSC 7818, Bethesda, MD 20892, (301) 435–
2359, shayiqr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Social
E:\FR\FM\04OCN1.SGM
04OCN1
]]>Agencies
[Federal Register Volume 72, Number 192 (Thursday, October 4, 2007)]
[Notices]
[Page 56780]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-4931]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute On Drug Abuse; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, MIDARP Review.
Date: November 14, 2007.
Time: 12 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6101 Executive Boulevard,
Rockville, MD 20852, (Telephone Conference Call).
Contact Person: Mark Swieter, PhD, Chief, Training and Special
Projects Review Branch, Office of Extramural Affairs, National
Institute on Drug Abuse, NIH, DHHS, 6101 Executive Boulevard, Suite
220, Bethesda, MD 20892-8401, (301) 435-1389, ms80x@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug
Abuse and Addiction Research Programs, National Institutes of
Health, HHS)
Dated: September 27, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-4931 Filed 10-03-07; 8:45 am]
BILLING CODE 4140-01-M
